Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KURT W LESH

Allopathic & Osteopathic Physicians Family Medicine

NPI
1780629824
CMS profile
216969
Location
COLORADO SPGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$5,004.34

140 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,002.43 132
Travel and Lodging $1,896.66 6
Education $105.25 2

By paying entity

PY2019 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KURT W LESH

NPI 1780629824 · CMS profile ID 216969

Allopathic & Osteopathic Physicians / Family Medicine

COLORADO SPGS, CO

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1780629824?year=2019&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KURT W LESH, NPI 1780629824, CMS profile ID 216969. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1780629824?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). KURT W LESH, NPI 1780629824, CMS profile ID 216969. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1780629824?year=2019&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
KURT W LESH, NPI 1780629824, CMS profile ID 216969, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 140 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1780629824?year=2019&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

140 matching records · $5,004.34 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 140 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 140.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Allergan Inc. $244.2408/11/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670718201 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.5308/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700117661 CMS
AstraZeneca Pharmaceuticals LP $11.3108/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685809151 CMS
Astellas Pharma US Inc $17.7608/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655658309 CMS
SANOFI-AVENTIS U.S. LLC $15.7607/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694116069 CMS
Allergan Inc. $5.8007/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670718177 CMS
Merck Sharp & Dohme Corporation $18.3107/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695676541 CMS
Vertiflex, Inc. $12.2907/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 669457259 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.7607/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700117663 CMS
E.R. Squibb & Sons, L.L.C. $14.9507/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651332883 CMS
GlaxoSmithKline, LLC. $23.6006/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671488937 CMS
PFIZER INC. $2.1906/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672416723 CMS
Amgen Inc. $109.0106/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662615875 CMS
Amarin Pharma Inc. $3.3006/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699158761 CMS
Amgen Inc. $12.9006/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662615893 CMS
Lilly USA, LLC $8.9506/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657963789 CMS
Merck Sharp & Dohme Corporation $13.3306/06/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695897195 CMS
Nevro Corp. $29.1506/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679665759 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.5906/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700117665 CMS
PFIZER INC. $8.0306/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672441715 CMS
Astellas Pharma US Inc $23.3505/29/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655658307 CMS
Lilly USA, LLC $12.5005/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657974125 CMS
Janssen Pharmaceuticals, Inc $5.2605/24/2019 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658913353 CMS
Mannkind Corporation $14.7705/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 705571539 CMS
Nevro Corp. $24.4505/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 679665767 CMS
E.R. Squibb & Sons, L.L.C. $16.4505/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651332871 CMS
AbbVie, Inc. $70.5405/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 647785897 CMS
Janssen Pharmaceuticals, Inc $14.5105/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658913349 CMS
Amgen Inc. $12.9705/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662615863 CMS
Merck Sharp & Dohme Corporation $13.3605/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695891403 CMS
Lilly USA, LLC $9.4705/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657956907 CMS
Amarin Pharma Inc. $93.8705/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699139687 CMS
AstraZeneca Pharmaceuticals LP $14.2205/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685480965 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.8205/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700117667 CMS
TherapeuticsMD, Inc. $15.1505/07/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703064335 CMS
AstraZeneca Pharmaceuticals LP $12.2105/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 685737157 CMS
Merck Sharp & Dohme Corporation $17.4705/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695443311 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $7.5705/02/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 700117669 CMS
Lilly USA, LLC $10.1205/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657963791 CMS
PFIZER INC. $4.6504/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672438022 CMS
Ultragenyx Pharmaceutical Inc. $6.2104/24/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703132529 CMS
Lilly USA, LLC $6.5404/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 657953499 CMS
E.R. Squibb & Sons, L.L.C. $14.9604/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 651332859 CMS
Janssen Pharmaceuticals, Inc $13.3104/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658913347 CMS
Amarin Pharma Inc. $5.2804/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 699121245 CMS
PFIZER INC. $109.0104/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672432971 CMS
PFIZER INC. $1.0104/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 672439109 CMS
Merck Sharp & Dohme Corporation $13.6304/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695892559 CMS
Amgen Inc. $106.9404/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662615883 CMS
Amgen Inc. $14.6604/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 662615889 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $5,004.34 140
PY2020 $1,265.97 64
PY2021 $764.58 30

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021
Generated from
OP_DTL_GNRL_PGYR2021_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2021 Principal investigator $25,582.06 14
PY2020 Principal investigator $235,448.51 139
PY2019 Recipient $1,742.78 4
PY2019 Principal investigator $194,140.22 88

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $981.41 12/31/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC. COLORADO SPRINGS FAMILY PRACTICE
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 When administered Concomitantly with Influenza Vaccine in Healthy Adults 50 Years of Age or Older PNEU FLU No dispute reported 06/30/2026 937746169
Principal investigator 1 Allergan, Inc. $300.00 06/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020869
Principal investigator 1 Allergan, Inc. $150.00 06/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020871
Principal investigator 1 Allergan, Inc. $184.00 06/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020873
Principal investigator 1 Allergan, Inc. $1,600.00 06/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020875
Principal investigator 1 Allergan, Inc. $50.00 06/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020877
Principal investigator 1 Allergan, Inc. $1,500.00 03/01/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020867
Principal investigator 1 Allergan, Inc. $1,925.90 02/18/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 12-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020859
Principal investigator 1 Allergan, Inc. $91.50 02/18/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 52-week, double blind, Phase 3 Study for Assessment of the Safety and Effectiveness of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020861
Principal investigator 1 Allergan, Inc. $299.25 02/18/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
46 weeks, placebo controlled (pts from 01/02 studies roll over for 53 weeks total exposure) No dispute reported 06/30/2026 789020863
Principal investigator 1 Allergan, Inc. $1,500.00 02/18/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
46 weeks, placebo controlled (pts from 01/02 studies roll over for 53 weeks total exposure) No dispute reported 06/30/2026 789020865
Principal investigator 1 Allergan, Inc. $1,500.00 02/17/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH LIMITED
A 52-week, double blind, Phase 3 Study for Assessment of the Safety and Effectiveness of Relamorelin in Patients with Diabetic Gastroparesis No dispute reported 06/30/2026 789020857
Principal investigator 1 SANOFI PASTEUR INC. $5,000.00 01/12/2021 Non-covered Recipient Entity
Clinical Research Advantage Incorporation
Immunogenicity and Safety of SARS-CoV-2 Recombinant Protein Vaccines With AS03 Adjuvant in Adults 18 Years of Age and Older as a Primary Series and Immunogenicity and Safety of a Booster Dose of SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (Two Monovalent and One Bivalent) No dispute reported 06/30/2026 838354991
Principal investigator 1 Merck Sharp & Dohme Corporation $10,500.00 01/06/2021 Non-covered Recipient Entity
SYNEXUS CLINICAL RESEARCH US, INC. PREMIER FAMILY MEDICINE, PC
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability, Efficacy, and Immunogenicity of V591 MV SARS-CoV-2, Live, Recombinant in Healthy Individuals 16 Years of Age or Older No dispute reported 06/30/2026 848761331